Schneider Electric today announced that its Wuxi factory in China, has been recognized by the World Economic Forum as a ...

Surpassing 10 GW is a testament to our strategic vision and technological excellence, said Xiaohua (Jimmy) Xu, Chairman and ...

S&P Global has listed the top 10 most shorted stocks in Hong Kong recently. The data is calculated based on the securities ...

Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, ...

According to the latest study from BCC Research, the demand for Conventional and Alternative Pain Treatment Markets is expected to grow from $96.2 billion in 2024 to $144.2 billion by the end of 2029, ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

WuXi Biologics agreed to sell an overseas vaccine facility to Merck & Co. for half a billion dollars, a move that could strengthen the company's cash flow and margins as it navigates global ...

WuXi Biologics (stock code: 2269) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and ...

China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 ...

The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside ...

Beijing will accelerate work to protect and utilize cultural relics in its core functional areas, and promote public access ...